| Application no. and date | 12768967.7 (espacenet) (Federated) (European Patent Register), 20120914 | | Patent/reg. no. and date | DK/EP 2709613, 20171129 | | Publication date | 20140326 | | Priority no. and date | US 201161535885 P, 20110916, US 201161561753 P, 20111118 | | EP pub. no. and date |
EP 2709613 20140326 | | Effective date | | | Applicant/owner | Gilead Pharmasset LLC, c/o Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404, US | | Applicant ref. no. | V156082DK | | Inventor | OLDACH, David W., 9111 Laurel Springs Drive
Chapel Hill, North Carolina 27516, US,
RAY, Adrian S., c/o Gilead Pharmasset LLC
333 Lakeside Drive
Foster City, CA 94404, US,
WATKINS, William J., c/o Gilead Pharmasset LLC
333 Lakeside Drive
Foster City, CA 94404, US,
LINK, John O., c/o Gilead Pharmasset LLC
333 Lakeside Drive
Foster City, CA 94404, US,
DELANEY, IV, William E., c/o Gilead Pharmasset LLC
333 Lakeside Drive
Foster City, California 94404, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/381 (2006.01) , A61K 31/4184 (2006.01) , A61K 31/4196 (2006.01) , A61K 31/513 (2006.01) , A61P 31/14 (2006.01) | | Title | FREMGANGSMÅDER TIL BEHANDLING AF HCV | | Int. application no. | US2012055621 | | Int. publication no. | WO2013040492 | | Related patent (certificate) | | | Status | Ændret DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
